Non-Hodgkin Lymphoma
News
Research explains why cisplatin causes hearing loss
Researchers have gained new insight into hearing loss caused by cisplatin. By measuring and mapping cisplatin retention in mouse and human inner...
News
Drug receives fast track, orphan designations for PTCL
The US Food and Drug Administration (FDA) has granted orphan drug and fast track designations to tenalisib (RP6530) for the treatment of...
Conference Coverage
Chemo-free combo should be option for rel/ref CLL, doc says
ATLANTA—The combination of venetoclax and rituximab (VR) should be a standard treatment option for adults with relapsed/refractory chronic...
Conference Coverage
Risk stratification may be possible with JCAR017
ATLANTA—Data suggest a therapeutic window may exist for chimeric antigen receptor (CAR) T-cell expansion with JCAR017, according to a preliminary...
News
Pembrolizumab sBLA receives priority review
The US Food and Drug Administration (FDA) has granted priority review to a supplemental biologics license application (sBLA) for the anti-PD-1...
News
Technique may be effective for diagnosing NHL
Preclinical research suggests infrared spectroscopy could be used to diagnose non-Hodgkin lymphoma (NHL). Researchers used mid-infrared...
News
Combo prolongs survival in lymphoma models
Combination treatment with 2 monoclonal antibodies (mAbs) has demonstrated preclinical efficacy against B-cell lymphomas, according to researchers...
News
Inhibitor exhibits activity against range of lymphomas
Preclinical research suggests the dual PI3K/mTOR inhibitor PQR309 has activity against several types of lymphoma and works well in combination...
News
Mogamulizumab BLA receives priority review
The US Food and Drug Administration (FDA) has accepted for priority review the biologics license application (BLA) for mogamulizumab....
News
How CLL patients weigh treatment efficacy, safety, and cost
New research suggests patients with chronic lymphocytic leukemia (CLL) are willing to trade treatment efficacy for a reduced risk of side effects...
News
Review suggests low incidence of BIA-ALCL in Canada
Results of a safety review suggest there is a low incidence of breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) in Canada....